| Dr Tasha Dee Standing Soldier, PHARMD | |
|
2900 Doolittle Drive, 28th Medical Group, Ellsworth Afb, SD 57706 | |
| (605) 385-3250 | |
| Not Available |
| Full Name | Dr Tasha Dee Standing Soldier |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 2900 Doolittle Drive, Ellsworth Afb, South Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467501874 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 5464 (South Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tasha Dee Standing Soldier, PHARMD 1208 Clover Ridge Dr, Rapid City, SD 57701-2115 Ph: (605) 385-0325 | Dr Tasha Dee Standing Soldier, PHARMD 2900 Doolittle Drive, 28th Medical Group, Ellsworth Afb, SD 57706 Ph: (605) 385-3250 |
News Archive
Jazz Pharmaceuticals, Inc. announced financial results for the second quarter ended June 30, 2010 and updated financial guidance for 2010. The company's updated financial guidance reflects higher expected sales of XYREM® (sodium oxybate) and the effects of recent financing activities.
The U.S. Army has awarded University of Montana researcher Dave Poulsen a $1 million grant to further develop a drug that limits damage caused by traumatic brain injuries.
Barth Syndrome (BTHS) is a rare and serious genetic disorder that primarily affects males and is passed from mother to son; women who are carriers do not show symptoms of the disorder. Fifty percent of children born to a mother who is a carrier will inherit the defective gene, and all daughters born to an affected man will be carriers. BTHS is caused by a mutation in the tafazzin gene that results in decreased production of cardiolipin, an essential lipid for energy metabolism.
VeraLight Inc., the first company to develop an optical skin measurement for noninvasive diabetes screening, and Pear Healthcare Solutions Inc., a leading provider of in-pharmacy health screening and education services, today announced an agreement for the distribution of the SCOUT DS device in pharmacies across Canada.
Final results of the randomized intergroup EORTC, LYSA (Lymphoma Study Association), FIL (Fondazione Italiana Linfomi) H10 trial presented at the 13th International Conference on Malignant Lymphoma in Lugano, Switzerland, on 19 June 2015 show that early FDG-PET ( 2-deoxy-2[F-18]fluoro-D-glucose positron emission tomography) adapted treatment improves the outcome of early FDG-PET-positive patients with stages I/II Hodgkin lymphoma.
› Verified 2 days ago
Dr. Eric Walter Jorczak, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2900 Doolittle Dr, Ellsworth Afb, SD 57706 Phone: 605-385-3250 | |
Brandon Hey, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2900 Doolittle Dr Bldg 6000, Ellsworth Afb, SD 57706 Phone: 605-385-6700 | |
Dr. Anh N Ison, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2900 Doolittle Dr, Ellsworth Afb, SD 57706 Phone: 605-385-6700 | |
Dr. Joshua M Elston, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2900 Doolittle Dr, Ellsworth Afb, SD 57706 Phone: 605-385-6700 | |
Dr. Jeffrey Moran, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2900 Doolittle Dr, Ellsworth Afb, SD 57706 Phone: 605-385-3355 | |
Mr. Craig A Lequatte, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2900 Doolittle Dr, Ellsworth Afb, SD 57706 Phone: 605-385-3252 |